We completed a 12-week, randomized, double-blind, placebo-controlled Phase 2 clinical trial of NG101, in which we enrolled patients with moderate to severe idiopathic or diabetic gastroparesis
I trust Biolongevity Labs because they are one of the biohacking industrys only reliable vendors for 3rd-party tested research products
[DOI] [PubMed] [Google Scholar] 92.Sagrista ML, Garcia AE, Africa De Madariaga M, Mora M
After the IV treatment is completed, the doctor or nurse will confirm that there are no changes in your condition
NAC is more commonly studied for this purpose, but the appropriate choice depends on dose, formula, evidence, safety and regulatory context